339 related articles for article (PubMed ID: 25635756)
21. Hematopoietic stem cell transplantation for myelofibrosis: where are we now?
Fleischman AG; Maziarz RT
Curr Opin Hematol; 2013 Mar; 20(2):130-6. PubMed ID: 23314844
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
Servais S; Baron F; Beguin Y
Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
[TBL] [Abstract][Full Text] [Related]
23. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
[TBL] [Abstract][Full Text] [Related]
24. Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis.
Alchalby H; Kröger N
Curr Hematol Malig Rep; 2010 Apr; 5(2):53-61. PubMed ID: 20425397
[TBL] [Abstract][Full Text] [Related]
25. Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis.
Gupta V; Gotlib J; Radich JP; Kröger NM; Rondelli D; Verstovsek S; Deeg HJ
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1274-81. PubMed ID: 24680977
[TBL] [Abstract][Full Text] [Related]
26. Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis.
Nagi W; Lim ZY; Krishnamurthy P; Potter V; Tindell V; Reiff-Zall L; Abdullah A; Lea N; Kenyon M; Marsh J; Ho AY; Mufti GJ; Pagliuca A
Leuk Res; 2011 Aug; 35(8):998-1000. PubMed ID: 21704371
[TBL] [Abstract][Full Text] [Related]
27. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation for adult primary myelofibrosis: retrospective analysis by Fukuoka BMT group].
Kamimura T; Yong C; Ito Y; Henzan H; Miyamoto T; Ohno Y; Eto T; Takenaka K; Akashi K
Rinsho Ketsueki; 2012 Mar; 53(3):323-8. PubMed ID: 22499049
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic stem cell transplantation as treatment for myelofibrosis.
Papageorgiou SG; Castleton A; Bloor A; Kottaridis PD
Bone Marrow Transplant; 2006 Dec; 38(11):721-7. PubMed ID: 17013423
[TBL] [Abstract][Full Text] [Related]
29. 2021 Update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management.
Ali H; Bacigalupo A
Am J Hematol; 2021 Nov; 96(11):1532-1538. PubMed ID: 34536293
[TBL] [Abstract][Full Text] [Related]
30. [Allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms].
Takenaka K
Rinsho Ketsueki; 2019; 60(9):1148-1156. PubMed ID: 31597838
[TBL] [Abstract][Full Text] [Related]
31. The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review.
Tiribelli M; Palandri F; Sant'Antonio E; Breccia M; Bonifacio M
Bone Marrow Transplant; 2020 Apr; 55(4):708-716. PubMed ID: 31534197
[TBL] [Abstract][Full Text] [Related]
32. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
[TBL] [Abstract][Full Text] [Related]
33. [Stem cell transplantation in myelofibrosis].
Toivari A; Itälä-Remes M; Kauppila M; Putkonen M; Salmenniemi U; Remes K
Duodecim; 2011; 127(22):2375-82. PubMed ID: 22238916
[TBL] [Abstract][Full Text] [Related]
34. European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party.
McLornan DP; Sirait T; Hernández-Boluda JC; Czerw T; Hayden P; Yakoub-Agha I
Curr Res Transl Med; 2021 Jan; 69(1):103267. PubMed ID: 33069640
[TBL] [Abstract][Full Text] [Related]
35. Improving allogeneic stem cell transplantation in myelofibrosis.
Gagelmann N; Kröger N
Int J Hematol; 2022 May; 115(5):619-625. PubMed ID: 35419771
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care.
Koehne G; Giralt S
Curr Opin Oncol; 2012 Nov; 24(6):720-6. PubMed ID: 22960558
[TBL] [Abstract][Full Text] [Related]
37. Role of hematopoietic stem cell transplantation in patients with myeloproliferative disease.
Salit RB; Deeg HJ
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1023-35. PubMed ID: 25459177
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.
Deeg HJ; Bredeson C; Farnia S; Ballen K; Gupta V; Mesa RA; Popat U; Hari P; Saber W; Seftel M; Tamari R; Petersdorf EW
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1883-7. PubMed ID: 26371371
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.
Zang DY; Deeg HJ
Curr Opin Hematol; 2009 Mar; 16(2):140-6. PubMed ID: 19468277
[TBL] [Abstract][Full Text] [Related]
40. [Allogeneic hematopoietic cell transplantation for myeloproliferative neoplasms].
Takenaka K
Rinsho Ketsueki; 2023; 64(10):1306-1313. PubMed ID: 37914246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
